To assess whether the psychological variables perceived stress, neuroticism and coping strategies, are associated with Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Syndrome (PMDD).
Women consulting for troubles related to menstruation and for other motives such as screening for uterine cancer, contraception counselling or desire for pregnancy.
285 PMS and 285 age-matched controls, as well as 88 PMDD cases and 176 controls participated in the study. Medium and high levels of perceived stress were associated with an increase in the odds of PMS (Odds Ratio (OR) = 2.49; 95%CI: 1.41–4.39 and OR = 4.90; 95%CI: 2.70–8.89, respectively). For PMDD the results were: OR = 2.61; 95%CI: 1.35–5.05 and OR = 5.79; 95%CI: 2.63–12.76, respectively.
Subjects with medium and high levels of neuroticism were also at higher odds of suffering from PMS (OR = 2.53; 95%CI: 1.06–6.06 and OR = 8.05; 95%CI: 3.07–2.12, respectively). For PMDD, the results were OR = 3.70; 95%CI: 1.27–10.77 and 5.73: 95%CI: 1.96–16.77, respectively.
High levels in the large majority of coping strategies were also associated with increased odds of PMS and PMDD.
Citation: del Mar Fernández M, Regueira-Méndez C, Takkouche B (2019) Psychological factors and premenstrual syndrome: A Spanish case-control study. PLoS ONE 14(3): e0212557. https://doi.org/10.1371/journal.pone.0212557
Editor: Nülüfer Erbil, Ordu University, TURKEY
Received: July 16, 2018; Accepted: February 5, 2019; Published: March 6, 2019
Copyright: © 2019 del Mar Fernández et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and Supporting Information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Premenstrual syndrome (PMS) and its most severe form, Premenstrual Dysphoric Disorder (PMDD), are defined as the set of recurrent physical and psychic symptoms in the luteal phase of the menstrual cycle. Although classified separately, both clinical groups have a common pathophysiological basis.
While the prevalence of PMS varies between 20% and 40%, that of PMDD sways between 3 and 8% in women of childbearing age in the United States. Worldwide, according to a recent meta-analysis, about half of women suffer from this syndrome.
PMS affects the daily life of women as it interferes with work, study, and interpersonal relationships[3,5]. The annual total costs per woman in the US were estimated at $ 5,000. A large proportion of cases is not diagnosed due to the difficulties encountered by the physicians in establishing a diagnosis and to the fact that women do not usually consult a doctor when they present symptoms of PMS. These difficulties often relate to gender bias. Indeed, part of the community of health professionals is reluctant to diagnose a syndrome that they consider a mere cultural and social construct and not a real disease.
As a result, despite the high frequency of the syndrome, the burden of women seeking medical help and receiving a diagnosis is small and is probably declining. It is remarkable that, before receiving a diagnosis, these women, on average, had sought medical help for 5.33 years from 3.75 physicians.
Previous studies have related PMS/PMDD and psychological and personality factors, such as psychological stress, coping styles and neuroticism[10–16]. However, these studies often use a cross-sectional design which hinders any causal inference.
Although disagreement exists about the meaning of the term “stress”, a common core concept refers to a process in which external demands (also called stressors) exceed the adaptation capacity of the organism and cause undesirable psychological and biological changes. To cope with stress, several styles are used, including positive reframing, religious behavior or even substance use. These coping strategies are linked to personality types such as neuroticism. Neuroticism is a stable personality trait that can be defined as the individual’s inadequate response to stress and is characterized by instability and emotional insecurity, high levels of anxiety, along with psychosomatic symptoms. It has been shown that subjects with a high degree of neuroticism tend to use avoidance or support coping strategies.
The objective of this study is, therefore, to investigate whether perceived stress, coping styles and neurotic personality are associated with premenstrual syndrome.
We set up a case-control study with newly diagnosed cases of PMS and PMDD. We selected 285 consecutive cases of PMS among women consulting for troubles related to menstruation and 285 controls. Motives of consultation included: heavy menstrual bleeding, hypomenorrhea, irregular menstruation cycles, amenorrhea and dysmenorrhea. We also selected 88 cases of PMDD and 176 controls. Participants were selected from three major public hospitals and one family counseling and planning center in the city of Santiago de Compostela and surroundings (Northwest Spain), which attend a population of approximately 400,000 users. Controls were individually age-matched to cases in each center.
All participants signed a consent form. The study was approved by Comité Ético de Investigación Clínica de Galicia n°2011/117, PI: Carlos Regueira-Méndez.
We collected the data through an anonymous, voluntary and self-completed questionnaire. Participants were selected by gynecologists and midwives of each center.
The questionnaire included a series of items about potential confounders of the relationship between psychological and personality variables and PMS, such as symptoms related to menstruation, socio-demographic factors, constitutional factors and other lifestyle factors.
To determine cases, we used the PSST (Premenstrual Syndrome Screening Tool) questionnaire, which consists of 19 questions about physical, behavioral and psychological symptoms in the five days before menstruation of the previous three months. The severity of each symptom was graded from 1 to 4 (1: none, 4: severe). The score obtained from this questionnaire, together with the presence of specific symptoms such as irritability and nervousness were used to differentiate between PMS and PMDD.
To define a PMS or PMDD case, the following algorithm was used. First, to label a case as PMS, we required a score ≥ 3 in one of the four questions about whether the women felt "irritable", "tense", "tearful" or "depressed". To define a PMDD case, we required a score of 4 in one of these same four questions. Furthermore, to define a case of PMS, a score ≥ 3 in one of the five variables of interference with "work performance, relationship with colleagues, family members, in social life or in household tasks" was required. Again, this score had to be 4 to define a case of PMDD. The last condition to be met to define PMS and PMDD cases is a score ≥ 3 in at least four of the first 14 questions (i.e. all questions except the five questions related to interference). Patients that did not meet the requirements were excluded from the study.
Controls were selected from women who attended the same health facility as cases but for motives different from PMS such as screening for uterine cancer, contraception counselling or desire for pregnancy. We confirmed the absence of PMS using the same questionnaire as above. The controls were required to have a score ≤2 in each item that described whether they felt "irritable", "tense", "tearful" or "depressed" and also a score ≤ 2 on all the interference variables described above.
We measured psychologic stress during the last three months by means of the scale of perceived stress proposed by Cohen et al. and validated in a Spanish population .
To assess coping styles, we used the scale proposed by Carver et al. which differentiates 14 types of coping, each of them evaluated by two items graded from 0 to 3. Additionally, we computed an average coping score by adding the scores of the 28 items divided by 28.
The degree of neuroticism was measured using 12 items of the scale proposed by Costa and McCrae (60 items).
We used conditional logistic regression to obtain crude and adjusted Odds Ratios and their corresponding 95% confidence intervals. We conducted separate analyses for PMS and PMDD. Continuous variables that did not follow a normal distribution were log-transformed and those variables the distribution of which still showed important asymmetry after logarithmic transformation were divided into quartiles or terciles, according to the range of their distribution.
In the final model, those variables that modified the estimate of the OR of psychological variables by more than 10% were introduced. These variables had shown previously some association with the risk of PMS in the univariate analysis. The final model included the following variables: number of hours of sleep, satisfaction with the quality of sleep and age of menarche.
The following candidate variables were analyzed for potential inclusion in the model but were finally discarded: menstrual irregularity, dysmenorrhea, number of pregnancies, antecedents of abortions, use of anovulants and intrauterine device, treatment with antidepressants, caffeine intake, alcohol intake, intake of various nutrients, and total energy expenditure.
The analyses were performed with STATA version 12.
We included 285 cases with PMS and 285 age-matched controls (case-control ratio 1:1), as well as 88 cases with PMDD and their 176 corresponding age-matched controls (case-control ratio 1:2). The response rate was 80% among initially approached cases and 80% in controls. The average age was 32 years for cases and controls, both for PMS and PMDD. Due to the low number of partial missing data, and thus, the fact that these missing data could not sensibly modify the results, we did not perform any imputation procedure.
In Table 1 we observe that PMS cases had an earlier menarche and a lower body mass index than the control group, as well as a higher proportion of nulliparous women. Due to the fact that the city in which this case-control study was carried out is a university city, a large proportion of the sample had high educational level. PMS cases had higher education than controls. In Table 2, this imbalance is also observed between PMDD cases and their controls.
Effect of psychosocial and personality variables on PMS
The data of the relation between PMS and psychosocial and personality variables are shown in Table 3.
Medium and high levels (3rd and 4th quartiles of the distribution) of perceived stress are strongly associated with PMS: OR = 2.49, 95% CI: 1.41–4.39 and OR = 4.90, 95% CI: 2.70–8.89, respectively. Furthermore, medium and high levels of neuroticism exert a similar effect on PMS (OR = 2.61, 95% CI: 1.35–5.05 and OR = 5.79; 95% CI: 2.63–12.76 respectively).
Table 4 shows that high levels of total coping score (4th quartile) are also related to PMS (OR = 3.26; 95% CI: 1.70–6.24). Furthermore, high levels of the following coping strategies were associated with a considerable increase in the odds of PMS: “planning” (OR = 2.17; 95% CI: 1.19–3.96), “use of emotional support” (OR = 2.06; 95% CI: 1.16–3.66), “use of instrumental support” (OR = 2.14; 95% CI: 1.24–3.70), “self-distraction” (OR = 2.39; 95% CI: 1.35–4.23), “venting” (OR = 2.56; 95% CI: 1.37–4.79), behavioural disengagement (OR = 2.58; 95% CI: 1.16–5.75), and self-blame (OR = 4.57; 95% CI: 2.40–8.73). Substance use was also strongly associated with PMS (OR = 2.50; 95% CI: 1.46–4.28).
Effect of psychosocial and personality variables in PMDD
Globally, the results for PMDD resemble those obtained for PMS (Table 3). Medium and high levels (3rd and 4th quartiles of the distribution) of perceived stress are associated with PMDD: OR = 2.53, 95% CI: 1.06–6.06 and OR = 8.05, 95% CI: 3.07–21.12, respectively. Furthermore, medium and high levels of neuroticism exert a similar effect on PMDD (OR = 3.70, 95% CI: 1.27–10.77 and OR = 5.73; 95% CI: 1.96–16.77 respectively).
High levels of total coping score (4th quartile) are related to the odds of PMDD (OR = 3.94; 95% CI: 1.58–9.79) (Table 5). Among the coping styles that showed an effect, medium levels of “active coping”, but not high levels, are associated with PMS (OR = 3.18; 95% CI: 1.23–8.20). Other coping strategies the high levels of which were strongly associated with PMDD were as follows: “planning” (OR = 3.98; 95% CI: 1.53–10.35), “use of instrumental support” (OR = 2.61; 95% CI: 1.11–6.15), “self-distraction” (OR = 4.58; 95% CI: 1.80–11.64), “venting” (OR = 3.17; 95% CI: 1.34–7.46), behavioural disengagement (OR = 5.06; 95% CI: 1.46–17.53), and self-blame (OR = 5.88; 95% CI: 2.43–14.20). As observed for PMS, substance use was also strongly associated with PMDD (OR = 5.95; 95% CI: 2.39–14.83).
Our findings indicate that high levels of psychological stress and neuroticism are strongly associated with PMS and PMDD. While the effect of high levels of neuroticism is similar in PMS and PMDD, that of perceived stress is considerably stronger in PMDD.
High levels of coping styles are also related to PMS and PMDD. Except for 4 out of 14 styles (positive reframing, acceptance, humor and turning to religion), PMS and PMDD cases were more susceptible to present high coping scores than controls. Carver et al. classify coping strategies in two broad patterns: “adaptive coping” which includes active coping, planning, positive reframing, acceptance, emotional and instrumental support; and “dysfunctional coping” which includes denial, behavioral disengagement, venting, substance use and self-distraction. The rest of coping styles was not explicitly assigned to one or another group. Our analysis did not find evidence of differences in the effect between the two coping patterns in PMS or PMDD.
Our results are in accordance with the several studies carried out on psychological factors and the development of PMS[10–16]. The large majority of these studies used a cross-sectional design and thus, are not optimal for causal inference purposes.
The effect observed in our study is not easily ascribed to confounding as a large set of potential confounders were considered in the analysis and estimates were not significantly modified when these potential confounders were introduced in the model.
The general view that is generally accepted is that psychological factors interact with physiological menstrual cycle changes and symptoms to produce distress. Some women respond to these cycle changes using dysfunctional coping. This maladaptation increases the premenstrual symptoms that are eventually labeled as PMS. Indeed, coping with PMS may be rendered extremely difficult due to male-centered values, behaviors and attitudes toward women suffering from this syndrome.
PMS is due to a hypersensitivity of the woman to changes in the activity of gonadal hormones and its development possibly involves complex interactions of hormonal, neural, and behavioral factors[28,29]. It has been suggested that the main etiological factor of this hypersensitivity is a genetically-determined predisposition. More specifically, holders of a polymorphism in the serotonin transporter promoter gene (5-HTTLPR) have been associated with a higher risk of PMS[16,30]. This genetic factor, not assessed in our study, could possibly play the role of effect modifier in the relation between psychological factors and PMS/PMDD. The effect of stress and neuroticism could then be different depending on whether women harbor this polymorphism or do not.
In our study, we cannot rule out some amount of misclassification in the PMS/PMDD assessment since the diagnosis is based on a subjective symptom score. Furthermore, this assessment, as in any case-control study, was carried out retrospectively. Some authors have suggested that retrospective assessment of PMS could potentially cause overreport of symptom severity, which could lead to the inclusion of subjects without true PMS in the case group. However, this misclassification bias, if any, is unlikely to modify the conclusion of this study because if there is any erroneous classification, it is likely that this error occurs regardless of the exposure status, since the subjects were not aware of the hypothesis of the study that related psychological factors and PMS. To explore the direction and magnitude of the potential bias due to misclassification of outcome, we reanalyzed the data by introducing the stress and neuroticism exposure variables as dichotomous (exposed/non-exposed). The resulting Odds Ratios were for PMS/perceived stress: 2.68 (95% CI: 1.78–4.06), PMS/neuroticism 3.61 (95% CI: 2.19–5.94), PMDD/perceived stress 4.34 (95% CI: 2.12–8.88), and PMDD/neuroticism 3.14 (95% CI: 1.62–6.08). These results suggest that the true association between these psychological factor and PMS may even be stronger than the one we have observed, as non-differential misclassification of a dichotomous variable always yield bias towards the null value, i.e decreases the effect.
Our study was a case-control study in which cases of PMS/PMDD were incident. Theoretically, the levels of perceived stress, neuroticism and coping refer to a time window that precedes the onset of the syndrome. However, it is not unlikely that the premenstrual symptoms, albeit in a less intense form, were concomitant to the assessment of psychological factors. A reverse causation process, in which the presence of premenstrual symptoms produces stress and inadequate coping strategies, cannot be ruled out. This could explain the fact that high levels of certain adaptive coping strategies, expected to reduce the odds of PMS/PMDD, were eventually associated with a large increase in the odds risk.
Furthermore, as in any case-control study, our study may be subject to recall bias. PMS/PMDD cases may better assess their psychological factors than controls. However, this is unlikely to occur as the participants were not aware of the hypothesis of the study. Indeed, the hypothesis of a relation between psychological factors and premenstrual syndrome was not disclosed to the participants, as these factors were only part of a long list of exposure factors that have been assessed in the questionnaire.
This case-control study found a strong association between psychological factors including perceived stress, neuroticism and coping strategies and the occurrence of PMS/PMDD. The association persisted after control for several risk factors and is unlikely to be due to misclassification bias. Although from a strict point of view a reverse causation process cannot be ruled out, due to the nature of the exposure factors explored, our findings are strengthened by the fact that they are in general agreement with previous work and by the biological plausibility of the relation between psychological stress and PMS/PMDD.
Future research on the etiology of PMS should abandon cross-sectional designs as suggested by PMS experts a decade ago. Indeed, this type of design does not allow for adequate causal inference, a fact that may render any finding deceptive. Stress reduction programs may be an effective prevention tool as recommended by experts. It has been shown that, in the long run, non-avoidant coping, also called attention coping, was associated with more positive outcomes. However, avoidant tactics may be more effective in the short run. Last, serious efforts should be made by the community of health professionals to modify prevailing cultural attitudes and overcome gender-biased detrimental decisions in the diagnosis and control of premenstrual syndrome.
S1 File. Questionnaire: Original Spanish Version.
- 1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: American Psychiatric Association; 2014.
- 2. O’Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson CN et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13–21.
- 3. Rapkin AJ, Winer SA. Premenstrual syndrome and premenstrual dysphoric disorder: Quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res. 2009;9(2):157–170. pmid:19402804
- 4. Direkvand-Moghadam A, Sayehmiri K, Delpisheh A, Kaikhavandi S. Epidemiology of premenstrual syndrome (PMS)-A systematic review and meta-analysis study. J Clin Diagn Res. 2014;8(2):106–109. pmid:24701496
- 5. Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dickerson V, et al. Health and economic impact of the premenstrual syndrome. J Reprod Med. 2003;48(7):515–524. pmid:12953326
- 6. Futterman LA, Rapkin AJ. Diagnosis of premenstrual disorders. J Reprod Med. 2006;51(4 Suppl):349–358. pmid:16734318
- 7. Browne TK. Is premenstrual dysphoric disorder really a disorder? J Bioeth Inq. 2015;12(2):313–330. pmid:25164305
- 8. Knaapen L, Weisz G. The biomedical standardization of premenstrual syndrome. Stud Hist Philos Biol Biomed Sci. 2008;39(1):120–134. pmid:18331959
- 9. Kraemer GR, Kraemer RR. Premenstrual syndrome: Diagnosis and treatment experiences. J Womens Health. 1998;7(7):893–907. pmid:9785316
- 10. Friedman D, Jaffe A. Influence of life-style on the premenstrual syndrome. analysis of a questionnaire survey. J Reprod Med. 1985;30(10):715–719. pmid:4067940
- 11. Gannon L, Luchetta T, Pardie L, Rhodes K. Perimenstrual symptoms: Relationships with chronic stress and selected lifestyle variables. Behav Med. 1989;15(4):149–159. pmid:2597778
- 12. Ramcharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol. 1992;45(4):377–392. pmid:1569434
- 13. Freeman EW, Rickels K, Schweizer E, Ting T. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med. 1995;25(2):309–315. pmid:7675918
- 14. Woods NF, Mitchell ES, Lentz MJ. Social pathways to premenstrual symptoms. Res Nurs Health. 1995;18(3):225–237. pmid:7754093
- 15. Yamamoto K, Okazaki A, Sakamoto Y, Funatsu M. The relationship between premenstrual symptoms, menstrual pain, irregular menstrual cycles, and psychosocial stress among japanese college students. J Physiol Anthropol. 2009;28(3):129–136. pmid:19483374
- 16. Gingnell M, Comasco E, Oreland L, Fredrikson M, Sundstrom-Poromaa I. Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR. Arch Womens Ment Health. 2010;13(5):417–423. pmid:20440524
- 17. Swartz MN. Stress and the common cold. N Engl J Med. 1991;325(9):654–656. pmid:1861700
- 18. Lahey BB. Public health significance of neuroticism. Am Psychol. 2009;64(4):241–256. pmid:19449983
- 19. Connor-Smith JK, Flachsbart C. Relations between personality and coping: A meta-analysis. J Pers Soc Psychol. 2007;93(6):1080–1107. pmid:18072856
- 20. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6(3):203–209. pmid:12920618
- 21. Takkouche B, Regueira C, Gestal-Otero JJ. A cohort study of stress and the common cold. Epidemiology. 2001;12(3):345–349. pmid:11338315
- 22. Carver CS. You want to measure coping but your protocol’s too long: Consider the brief COPE. Int J Behav Med. 1997;4(1):92–100. pmid:16250744
- 23. Costa PT, McCrae RR. Inventario de Personalidad NEO Revisado (NEO PI-R) e Inventario NEO Reducido de Cinco Factores (NEO FFI). Madrid: TEA Ediciones; 1999
- 24. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79(3):340–349. pmid:2916724
- 25. StataCorp. Stata statistical software: Release 12. College Station, TX: Stata Corp 2011.
- 26. Craner JR, Sigmon ST, Martinson AA. Self-focused attention in response to laboratory stressors among women with premenstrual disorders. Arch Womens Ment Health. 2015;18(4):595–606. pmid:25647070
- 27. Hoga LAK, Vulcano MA, Miranda CM, Manganiello A. Male behavior in front of women with premenstrual syndrome: Narratives of women. Acta Paul Enferm. 2010;23(3):372–378.
- 28. Bertone-Johnson ER, Whitcomb BW, Missmer SA, Manson JE, Hankinson SE, Rich-Edwards JW. Early life emotional, physical, and sexual abuse and the development of premenstrual syndrome: A longitudinal study. J Womens Health (Larchmt). 2014;23(9):729–739.
- 29. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology. 2003;28 Suppl 3:55–99.
- 30. Praschak-Rieder N, Willeit M, Winkler D, Neumeister A, Hilger E, Zill P et al. Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder. Eur Neuropsychopharmacol. 2002;12(2):129–134. pmid:11872329
- 31. Carver CS, Connor-Smith J. Personality and coping. Annu Rev Psychol. 2010;61:679–704. pmid:19572784
- 32. Gollenberg AL, Hediger ML, Mumford SL, Whitcomb BW, Hovey KM, Wactawski-Wende J et al. Perceived stress and severity of perimenstrual symptoms: The BioCycle study. J Womens Health. 2010;19(5):959–967.
- 33. Suls J, Fletcher B. The relative efficacy of avoidant and nonavoidant coping strategies: a meta-analysis. Health Psychol. 1985;4(3):249–88. pmid:4029107